Sutro Biopharma Inc (STRO)

Sutro Biopharma (STRO) Financial Statements


Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently ―. The company's EPS TTM is $-1.889; its P/E ratio is -2.04; Sutro Biopharma is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 113.72M$ 16.92M$ 10.41M$ 12.67M$ 8.63M
Gross Profit$ 113.72M$ 16.92M$ 10.41M$ 12.67M$ 11.42M
EBIT$ 55.60M$ -47.15M$ -37.97M$ -50.16M$ -35.75M
EBITDA$ 57.34M-$ -38.08M$ -50.33M$ -35.39M
Net Income Common Stockholders$ 31.07M$ -40.57M$ -38.52M$ -50.05M$ -34.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 375.62M$ 355.15M$ 391.64M$ 276.49M$ 334.36M
Total Assets$ 470.74M$ 431.73M$ 464.90M$ 358.02M$ 406.94M
Total Debt$ 33.63M$ 38.17M$ 42.66M$ 46.56M$ 50.43M
Net Debt$ -341.98M$ -316.98M$ -348.99M$ -229.93M$ -283.93M
Total Liabilities$ 321.09M$ 319.39M$ 310.18M$ 172.60M$ 189.90M
Stockholders Equity$ 149.65M$ 112.35M$ 154.70M$ 185.41M$ 217.05M
Cash Flow-
Free Cash Flow$ 12.63M-$ -31.20M$ -60.99M$ -23.86M
Operating Cash Flow$ 14.07M$ -33.50M$ -31.20M$ -60.99M$ -23.86M
Investing Cash Flow$ -23.51M$ -114.02M$ 66.16M$ 67.45M$ -37.88M
Financing Cash Flow$ -3.13M$ -5.74M$ 137.66M$ 8.76M$ 12.22M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis